Buys
Open market- Shares
- Avg price
- Total value
Blaine Davis - Chief Financial Officer at Cartesian Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Chief Financial Officer
- Issuer Symbol
- RNAC on Nasdaq
- All Insider Reports
- All Insider Reports
Blaine Davis - trading volume in the past year for Cartesian Therapeutics, Inc.
Sells
Open market- Shares
- -10,591
- Avg price
- $6.82
- Total value
- -$72,227
Net
Past year- Shares
- -10,591
- Share %
- -100%
- Total value
- -$72,227
Holdings reported by Blaine Davis for Cartesian Therapeutics, Inc.
Form 4 holding
Chief Financial Officer
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 121,220
- Estimated value
- $826,684
- Report date
- 06 Jan 2026
- Price
- $6.82
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
Cartesian Therapeutics, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 109,000
- Estimated value
- Report date
- 02 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Blaine Davis for Cartesian Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.